InsidersTradesSigma
Follow the 大参林 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 大参林 has logged 1 reports. Market capitalisation: €21.6bn. The latest transaction was reported on 16 August 2023 (Sale). Among the most active insiders: 陈洪. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
大参林是一家在上海证券交易所上市的医疗保健和制药领域的公司。它专注于药品和医疗保健产品的分销。